Journal
JOURNAL OF CONTROLLED RELEASE
Volume 331, Issue -, Pages 30-44Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2021.01.017
Keywords
Viral infections; Antivirals; Nanoparticles; Bioavailability; Nanotechnology
Funding
- University of Massachusetts, Amherst
Ask authors/readers for more resources
The global upheaval caused by the pandemic has highlighted the importance of effective antiviral treatments. Advanced antiviral delivery systems constructed using nanotechnology principles, particularly those utilizing natural substances, show promising potential to enhance drug stability and potency.
The COVID-19 pandemic has resulted in unprecedented increases in sickness, death, economic disruption, and social disturbances globally. However, the virus (SARS-CoV-2) that caused this pandemic is only one of many viruses threatening public health. Consequently, it is important to have effective means of preventing viral transmission and reducing its devastating effects on human and animal health. Although many antivirals are already available, their efficacy is often limited because of factors such as poor solubility, low permeability, poor bioavailability, un-targeted release, adverse side effects, and antiviral resistance. Many of these problems can be overcome using advanced antiviral delivery systems constructed using nanotechnology principles. These delivery systems consist of antivirals loaded into nanoparticles, which may be fabricated from either synthetic or natural materials. Nevertheless, there is increasing emphasis on the development of antiviral delivery systems from natural substances, such as lipids, phospholipids, surfactants, proteins, and polysaccharides, due to health and environmental issues. The composition, morphology, dimensions, and interfacial characteristics of nanoparticles can be manipulated to improve the handling, stability, and potency of antivirals. This article outlines the major classes of antivirals, summarizes the challenges currently limiting their efficacy, and highlights how nanoparticles can be used to overcome these challenges. Recent studies on the application of antiviral nano-particle-based delivery systems are reviewed and future directions are described.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available